Pharmacophores from Macromolecular Complexes with Ligandscout

Pharmacophores and Pharmacophore Searches

Volumn , Issue , 2006, Pages 131-150

  Wolber, Gerhard ^a   Kosara, Robert ^b  

^a Inte:Ligand GmbH   (Austria)

^b University of North Carolina at Charlotte   (United States)

Author keywords

3D interaction; 3D visualization; Application examples; Chemical feature based pharmacophores; Data source; LigandScout; Overlaying chemical features; Pharmacophore approaches; Pharmacophores; Pharmacophores from macromolecular complexes

Indexed keywords

DATA VISUALIZATION; MACROMOLECULES; THREE DIMENSIONAL COMPUTER GRAPHICS;

3-D INTERACTIONS; 3D VISUALIZATION; APPLICATION EXAMPLES; CHEMICAL FEATURES; DATA-SOURCE; LIGANDSCOUT; MACROMOLECULAR COMPLEXES; PHARMACOPHORES;

PHARMACODYNAMICS;

EID: 84952885456     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527609164.ch6     Document Type: Chapter

References (49)

1. T. Langer, R. Hoffmann, F. Bachmair, S. Begle. Chemical function based phar- macophore models as suitable filters for virtual screening. J.Mol. Struct. (THEO- CHEM) 503, 59-72, 2000.
2. W.P. Walters, M.T. Stahl, M.A. Murcko. Virtual screening-an overview. Drug Discov. Today, 3(4), 160-178, 1998.
3. T. Langer, G. Wolber. Lead optimization: pharmacophore definition and 3d searches. Drug Discov. Today, Technol., 1(3), 203-207, 2004.
4. SYBYL 6.6/FlexX. Tripos, St. Louis, MO.
5. M. Rarey, B. Kramer, T. Lengauer, G. Klebe. A fast flexible docking method using an incremental construction algo- rithm. J. Mol. Biol., 261, 470-489, 1996.
6. M. Rarey, B. Kramer, T. Lengauer, G. Klebe. Multiple automatic base selection: Protein-ligand docking based on incre- mental construction without manual in- tervention. J. Comput.-Aided Mol. Des., 11, 369-384, 1997.
7. C.M. Oshiro, I.D. Kuntz. Flexible ligand docking using a genetic algorithm. J. Comput.-Aided Mol. Des., 9, 113-130, 1995.
8. G.M. Morris, DS. Goodsell, R.S. Halli- day, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson. Automated docking using a lamarckian genetic algorithm and em- pirical binding free energy function. J. Comput. Chem., 19, 1639-1662, 1998.
9. S.J. Weiner, P.A. Kollman, D.A. Case, U.C. Singh, C. Ghio, G. Alagona, S. Pro- feta, P. Weiner. A new force field for mo- lecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc., 106, 765-784, 1984.
10. G. Jones, P. Willett, R.C. Glen. Molecular recognition of receptor sites using a ge- netic algorithm with a description of des- olvation. J. Mol. Biol., 245, 43-53, 1995.
11. G. Jones, P. Willett, R.C. Glen, A.R. Leach, R. Taylor. Development and vali- dation of a genetic algorithm for flexible docking. J. Mol. Biol., 267, 727-748, 1997.
12. H.-J. Böhm. LUDI: Rule-based automatic design of new substituents for enzyme inhibitor leads. J. Comput.-Aided Mol. Des., 6, 593-606, 1992.
13. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne. The pro- tein data bank. Nucleic Acids Res., 28, 235-242, 2000.
14. Relibase: a Program for Searching Protein- Ligand Databases. Cambridge Crystallo- graphic Data Centre, Cambridge, 2000.
15. M. Hendlich, F. Rippmann, G. Barnick- el. BALI: automatic assignment of bond and atom types for protein ligands in the brookhaven protein databank. J. Chem. Inf. Comput. Sci., 37, 774-778, 1997.
16. R. Sayle. From Cruft to Content: Percep- tion of Molecular Connectivity from 3D Co- ordinates. Bioinformatics Group, Meta- phorics LLC, Santa Fe, NM, 2001.
17. PDB File Format Contents Guide, Version 2.2, 1996, available from the PDB con- sortium, Piscatway, NS and La Jolla, CA (www.pdb.org).
18. J. Westbrook, P. Bourne. STAR/mmCIF: an extensive ontology for macromolecu- lar structure and beyond bioinformatics. Bioinformatics, 16, 159-168, 2000.
19. S.R. Hall, N. Spadaccini. The STAR file: detailed specification. J. Chem. Inf. Com- put. Sci., 34, 505-508, 1994.
20. H. Bernstein, F. Bernstein, P. Bourne. pdb2cif: translating PDB entries into mmCIF format. J. Appl. Crystallogr., 31, 282-295, 1998.
21. J. Westbrook, Z. Feng, S. Jain, T.N. Bhat, N. Thanki, V. Ravichandran, G.L. Gilli- land, W. Bluhm, H. Weissig, D.S. Greer, P.E. Bourne, H.M. Berman. The protein data bank: unifying the archive. Nucleic Acids Res., 30, 245-248, 2002.
22. B. DuCharme. XML, the Annotated Speci- fication. Prentice-Hall PTR, Upper Sad- dle River, NJ, 1999.
23. T. Bray, J. Paoli, C.M. Sperberg-McQu- een, E. Maler. Extensible Markup Lan- guage (XML) 1.0, 2nd ed., The w3c con- sortium, Cambridge, MA, USA, 2000.
24. D.C. McArthur, An Extensible XML Sche- ma Definition for Automated Exchange of Protein Data: PROXIML (PROtein eXten- sIble Markup Language). University of Ca- lifornia, Santa Cruz, CA, 2001, available from http://xml.coverpages.org/ proximl.xml.
25. R.D. Brown, Y.C. Martin. The informa- tion content of 2D and 3D structural de- scriptors relevant to ligand-receptor bind- ing. J. Chem. Inf. Comput. Sci., 37, 1-9, 1997.
26. J. Gasteiger, C. Jochum. An algorithm for the perception of synthetically impor- tant rings. J. Chem. Inf. Comput. Sci., 19, 43-48, 1979.
27. W.T. Wipke, T.M. Dyott. Use of ring as- semblies in ring perception algorithm. J. Chem. Inf. Comput. Sci., 15, 140-147, 1975.
28. J.B. Hendrickson, D.L. Grier, A.G. Tocz- ko. Condensed structure identification and ring perception. J. Chem. Inf. Com- put. Sci., 24, 195-203, 1984.
29. R. Balducci, R.S. Pearlman. Efficient ex- act solution of the ring perception prob- lem. J. Chem. Inf. Comput. Sci., 34, 822- 831, 1994.
30. B.T. Fan, A. Panaye, J.P. Doucet, A. Bar- bu. Ring perception. A new algorithm for directly finding the smallest set of smallest rings from a connection table. J. Chem. Inf. Comput. Sci., 33, 657-662, 1993.
31. G.M. Downs, V.J. Gillet, J.D. Holliday, M.F. Lynch. Review of ring perception algorithms for chemical graphs. J. Chem. Inf. Comput. Sci., 29, 172-187, 1989.
32. J. Figueras. Ring perception using breadth-first search. J.Chem. Inf. Comput. Sci., 36, 986-991, 1996.
33. G. Wolber, T. Langer. Ligandscout: 3D pharmacophores derived from protein- bound ligands and their use as virtual screening filters. J. Chem. Inf. Model., 45, 160 -169, 2005.
34. G.R. Marshall, C.D. Barry, H.E. Bos- shard, R.A. Dammkoehler, D.A. Dunn. The conformational parameter in drug design: the active analog approach. In Computer-Assisted Drug Design, Vol. 112, E.C. Olson and R.E.Christoffersen (eds), American Chemical Society, Washington, DC, 1979, pp. 205-226.
35. J. Green, S. Kahn, H. Savoj, P. Sprague, S. Teig. Chemical function queries for 3D database search. J. Chem. Inf. Com- put. Sci., 34, 1297-1308, 1994.
36. E.M. Krovat, T. Langer. Non-peptide an- giotensin II receptor antagonists: chemi- cal feature based pharmacophore identi- fication. J. Med. Chem., 46, 716-726, 2003.
37. Smiles ARbitrary Target Specification (SMARTS). Daylight Chemical Informa- tion Systems, Mission Viejo, CA, http:// www.daylight.com/dayhtml/doc/theory/ theory.smarts.html.
38. L. Pauling. The Nature of the Chemical Bond, 2nd edn. Cornell University Press, Ithaca, NY, 1948.
39. A. Khan. A liquid water model: density variation from supercooled to super- heated states, prediction of H-bonds and temperature limits. J. Phys. Chem., 104, 11268-11274, 2000.
40. Catalyst, Version 4.10. Accelrys, San Die- go, CA, 2001.
41. G. Wolber, T. Langer. Combi Gen: a novel software package for the rapid genera- tion of virtual combinatorial libraries. In Rational Approaches to Drug Design, H.-D. Höltje and W. Sippl (eds), Prous Science, Barcelona, Spain, 2000, pp. 390-399.
42. W. Kabsch. A solution for the best rota- tion to relate to sets of vectors. Acta Crys- tallogr., Sect. A, 32, 922-923, 1976.
43. A. Halm, L. Offen, D.W. Fellner. Visuali- zation of complex molecular ribbon structures at interactive rates. In 8th In- ternational Conference on Information Vi- sualization (IV), IEEE Computer Society Press, Los Alamitos, CA, 2004, pp. 737- 744.
44. E.B. Goldstein. Sensation and Perception. Wadsworth Publishing, Belmont, CA, 2001.
45. C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney. Experimental and computational approaches to estimate solubility and permeability in drug dis- covery and development settings. Adv. Drug Del. Rev., 23, 3-25, 1997.
46. C.A. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Meth- ods, 44, 235-249, 2000.
47. S.A. Wildman, G.M. Crippen. Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comput. Sci., 39, 868-873, 1999.
48. A.T. Hadfield, G.T. Diana, M.G Ross- mann. Analysis of three structurally re- lated antiviral compounds in complex with human rhinovirus 16. Proc. Natl. Acad. Sci. USA, 96, 14730, 1999.
49. T. Schindler, W. Bornmann, P. Pellicena, W.T. Miller, B. Clarkson, J. Kuriyan. Structural mechanism for STI-571 inhi- bition of abelson tyrosine kinase. Science, 289, 1938, 2000.